Erratum

Erratum for the Research Article: “A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa” by A. Huttner, C. Combescure, S. Grillet, M. C. Haks, E. Quinten, C. Modoux, S. T. Agnandji, J. Brosnahan, J.-A. Dayer, A. M. Harandi, L. Kaiser, D. Medaglini, T. Monath, VEBCON and VSV-EBOVAC Consortia, P. Roux-Lombard, P. G. Kremsner, T. H. M. Ottenhoff, C.-A. Siegrist

See allHide authors and affiliations

Science Translational Medicine  21 Aug 2019:
Vol. 11, Issue 506, eaaz0296
DOI: 10.1126/scitranslmed.aaz0296

In the Research Article “A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa,” under “Identification of the Geneva signature” in the Materials and Methods, the standardizations for the plasma signature were incorrect. The signature itself is correct, and this error does not change the findings and conclusion of the study. The PDF and HTML (full text) have been corrected.

Navigate This Article